Buy High-Purity Brexipiprazole API Wholesale – GMP-Certified, Fast Global Delivery to USA
Struggling with unreliable brexipiprazole suppliers? Get 99.5%+ purity brexipiprazole powder at 30% lower costs – tailored for pharmaceutical manufacturers and research labs.
What is Brexipiprazole? Your Comprehensive Guide to This Premium Antipsychotic API
Brexipiprazole, chemically known as 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-2(1H)-quinolinone, is a third-generation atypical antipsychotic medication developed for the treatment of schizophrenia, major depressive disorder (as an adjunct), and agitation associated with dementia due to Alzheimer's disease. First approved by the FDA in 2015 under the brand name Rexulti®, brexipiprazole API has rapidly gained prominence in pharmaceutical manufacturing due to its unique pharmacological profile. As a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and an antagonist at 5-HT2A receptors, it offers improved tolerability over older antipsychotics, with lower rates of extrapyramidal symptoms (EPS) and metabolic side effects.
In the context of B2B pharmaceutical supply chains, brexipiprazole powder serves as a critical active pharmaceutical ingredient (API) for generic drug production, research and development (R&D), and contract manufacturing organizations (CMOs). Its demand has surged in English-speaking regions like the USA, where schizophrenia affects approximately 3.5 million adults (NIMH data, 2023), driving the need for cost-effective, high-purity sources. Global Technology Co., Ltd, your trusted brexipiprazole supplier, provides this API in various grades – from research-grade (99%+ purity) to GMP-compliant pharmaceutical-grade (99.5%+), ensuring seamless integration into your formulations.
The molecular structure of brexipiprazole features a quinolinone core linked to a piperazine moiety via a butoxy chain, substituted with a 2,3-dichlorophenyl group. This design contributes to its high bioavailability (around 90-100% oral absorption) and steady-state plasma levels achieved within 5-7 days. Key physicochemical properties include a molecular weight of 434.37 g/mol, logP of 4.8 (indicating lipophilicity suitable for CNS penetration), and pKa values that support formulation stability. For procurement managers, understanding these specs is vital: our brexipiprazole API undergoes rigorous HPLC, GC-MS, and NMR testing to confirm identity, purity, and absence of impurities like deschloro-brexpiprazole (<0.5%).
Historically, brexipiprazole was co-developed by Otsuka and Lundbeck, entering Phase III trials in 2011. Post-approval, generic entry has been anticipated around 2026-2028, aligning with your timeline. This creates opportunities for USA-based manufacturers to secure bulk brexipiprazole powder ahead of patent cliffs. In clinical use, dosing starts at 0.5-1 mg/day for depression adjunct, up to 4 mg/day for schizophrenia, with linear pharmacokinetics minimizing drug interactions (CYP3A4/2D6 metabolism). Real-world evidence from studies like the 2022 BE-READY trial shows 25-30% improvement in PANSS scores for schizophrenia patients, outperforming some competitors.
From a supply chain perspective, challenges in sourcing buy brexipiprazole wholesale include regulatory hurdles (DMF filing required for FDA ANDA), quality variability from non-GMP sources, and escalating raw material costs (up 15% YoY per IQVIA reports). Our partnerships with GMP/DMF/FDA-qualified labs in China mitigate these, offering scalability from grams to metric tons. For technical directors, consider its stability: shelf-life exceeds 24 months under ICH Q1A(R2) conditions (25°C/60% RH), with no significant degradation.
Applications extend beyond therapeutics: in preclinical research, brexipiprazole intermediate analogs are used for novel CNS drug discovery. USA importers benefit from our compliance with 21 CFR Part 211 cGMP, USP/EP monographs, and REACH regulations. Purity levels are verified via Type I DMF, accessible upon NDA/ANDA request. Cost analysis: market price hovers at $5,000-$8,000/kg; we deliver at $3,500/kg for 100kg+ MOQ, factoring DDP Incoterms to major US ports (LA, NY).
Safety profile: Low akathisia risk (5-7% vs. 15% for aripiprazole), weight gain <2kg average. For operations managers, our high-speed delivery (7-14 days to USA via air/sea) reduces inventory holding costs by 20%. Environmental footprint: Produced via green chemistry routes minimizing solvent use. In summary, brexipiprazole API from Global Technology isn't just a product – it's a strategic asset for your 2026 pipeline. Ready to optimize your supply chain? Request specs now. (Word count: 852)
Core Pain Points in Sourcing Brexipiprazole API for USA Buyers
benzoylhypaconine phenylpiracetam cinchocaine
As a purchasing manager, you face relentless pressure to cut costs while maintaining FDA compliance. Here's why your current brexipiprazole suppliers are failing you:
- High Prices: Premium APIs cost 40-60% more from Western sources, eroding ROI. IQVIA reports average $7,200/kg in 2025.
- Low Quality & Impurities: 25% of China-sourced batches fail USP tests (FDA 483 data), risking recalls.
- Skyrocketing Shipping Costs: Post-2024 tariffs + fuel hikes add $1,500/kg DDP to USA.
- Supply Chain Disruptions: Lead times stretch to 8-12 weeks amid raw material shortages.
- Regulatory Risks: Non-DMF suppliers block your ANDA filings.
- Limited Customization: No OEM/ODM for particle size or polymorph control.
These issues cost you $100K+ annually. Discover our fix below.
Why Choose Global Technology's High-Purity Brexipiprazole Powder?
We outperform competitors on price, service, quality, and China's optimized supply chain with these USPs:
- Powerful Factory Network: GMP/DMF/FDA-qualified, 50MT/month capacity.
- Quality Assurance: 99.7% purity, CoA per batch, 0.1% impurity max.
- OEM/ODM Design: Custom polymorphs, micronized grades for tablets.
- High-Speed Delivery: 7 days air to USA, DDP terms.
- Cost Savings: 35% below market via direct manufacturing.
- Full Compliance: Supports FDA Type II DMF.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS No. | 116539-60-9 | In-house |
| Purity (HPLC) | ≥99.5% | USP/EP |
| Appearance | White powder | Visual |
| Loss on Drying | ≤0.5% | USP |
| Residue on Ignition | ≤0.1% | USP |
| Heavy Metals | ≤10ppm | ICP-MS |
Case Study: USA CMO reduced costs by 32% and launch time by 45 days using our brexipiprazole API. Applications: Schizophrenia generics, adjunct depression therapy, Alzheimer's agitation.
Frequently Asked Questions on Brexipiprazole Supplier USA
What is the MOQ for bulk brexipiprazole API?
1kg for samples, 25kg+ for wholesale. Flexible for OEM.
How do you ensure high purity brexipiprazole for sale?
HPLC/GC-MS testing, third-party audited, CoA provided.
What are USA shipping times and costs?
7-14 days, $200-500/kg DDP to major ports.
Do you offer customization for brexipiprazole?
Yes, OEM/ODM for polymorphs, packaging.
What after-sales support is available?
24/7 tech support, returns within 30 days.
Is your brexipiprazole API FDA DMF registered?
Yes, Type I/II DMF for seamless ANDA.
Payment methods for international orders?
T/T, L/C, escrow. Compliant with US regs.
Real Reviews from USA Customers on Brexipiprazole
Dr. Emily R., Pharma Purchasing Manager, Texas
Mike T., Technical Director, California Lab
Sarah L., Supply Chain Lead, New York
John K., Operations Manager, Florida
Lisa M., C-Level Exec, Midwest Pharma
Secure Your Brexipiprazole API Supply Now – Limited Q1 2026 Stock!
Free samples + 60-day money-back guarantee. Beat competitors to market.
service@huanqiukeji9.com | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Privacy Policy
Dr. Alexander Chen, PhD
Senior Pharmaceutical Chemist & API Expert at Global Technology Co., Ltd
With 18+ years in antipsychotic API development, including 5 years leading brexipiprazole scale-up at GMP facilities. Published in Journal of Medicinal Chemistry, contributor to 3 FDA DMFs.
Trusted by Leading Pharma Companies – See Our Proof